Dr. Ali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 Loftis Blvd
Newport News, VA 23606Phone+1 757-873-9400
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- University of MarylandResidency, Internal Medicine, 2016 - 2019
- Virginia Commonwealth University School of MedicineClass of 2016
- Virginia Commonwealth UniversityBS, Biology, 2007 - 2011
Certifications & Licensure
- VA State Medical License 2022 - 2026
- TX State Medical License 2019 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsPeripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.Noa G. Holtzman, Firas El Chaer, Maria R. Baer, Omer Ali, Ameet Patel
British Journal of Haematology. 2020-03-01 - 18 citationsTreatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.Firas El Chaer, Omer Ali, Edward A. Sausville, Jennie Y. Law, Seung Tae Lee
American Journal of Hematology. 2019-01-01 - 3 citationsPrimary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.Akshat M Patel, Omer Ali, Radhika Kainthla, Syed M Rizvi, Farrukh T Awan
Neuro-Oncology Practice. 2022-05-01
Journal Articles
- Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital settingAkshat M Patel, Omer Ali, Radhika Kainthla, Syed M Rizvi, Farrukh T Awan, Toral Patel, Edward Pan, Elizabeth Maher, Neil B Desai, Robert Timmerman, Kiran A Kumar, Prav..., Neuro-Oncology Practice, 1/12/2022
Abstracts/Posters
- A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)Omer M Ali, MD, Sahil S Nalawade, MS, Yin Xi, PhD, Ben Wagner, BM, Alexander Mazal, MD, Shane Ahlers, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Kiran A Kumar, MD, MBA,..., American Society of Hematology 2020, 12/6/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: